ZA200609326B - Tri-substituted ureas as cytokine inhibitors - Google Patents
Tri-substituted ureas as cytokine inhibitorsInfo
- Publication number
- ZA200609326B ZA200609326B ZA200609326A ZA200609326A ZA200609326B ZA 200609326 B ZA200609326 B ZA 200609326B ZA 200609326 A ZA200609326 A ZA 200609326A ZA 200609326 A ZA200609326 A ZA 200609326A ZA 200609326 B ZA200609326 B ZA 200609326B
- Authority
- ZA
- South Africa
- Prior art keywords
- tri
- substituted ureas
- cytokine inhibitors
- cytokine
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Communicable Diseases (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56474504P | 2004-04-22 | 2004-04-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200609326B true ZA200609326B (en) | 2007-12-27 |
Family
ID=34967029
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200609326A ZA200609326B (en) | 2004-04-22 | 2006-11-09 | Tri-substituted ureas as cytokine inhibitors |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US7402589B2 (fr) |
| EP (2) | EP1747204B1 (fr) |
| JP (2) | JP2007534689A (fr) |
| KR (1) | KR100883937B1 (fr) |
| CN (2) | CN1946700A (fr) |
| AR (2) | AR050411A1 (fr) |
| AT (1) | ATE402927T1 (fr) |
| AU (1) | AU2005238484A1 (fr) |
| BR (1) | BRPI0510128A (fr) |
| CA (2) | CA2564589A1 (fr) |
| DE (1) | DE602005008581D1 (fr) |
| DK (1) | DK1747204T3 (fr) |
| ES (1) | ES2311223T3 (fr) |
| HR (1) | HRP20080489T3 (fr) |
| IL (1) | IL178459A0 (fr) |
| MA (1) | MA28638B1 (fr) |
| MX (2) | MXPA06012189A (fr) |
| NO (1) | NO20065142L (fr) |
| PE (2) | PE20060258A1 (fr) |
| PL (1) | PL1747204T3 (fr) |
| PT (1) | PT1747204E (fr) |
| RU (1) | RU2338739C2 (fr) |
| SI (1) | SI1747204T1 (fr) |
| SM (1) | SMAP200600037A (fr) |
| TW (2) | TW200538105A (fr) |
| WO (2) | WO2005105758A1 (fr) |
| ZA (1) | ZA200609326B (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102008060549A1 (de) | 2008-12-04 | 2010-06-10 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung |
| CN108976172B (zh) * | 2017-05-31 | 2021-12-07 | 华东师范大学 | 一类4-嘧啶二胺类小分子有机化合物及其衍生物及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6204261B1 (en) * | 1995-12-20 | 2001-03-20 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β Converting enzyme inhibitors |
| HU206337B (en) * | 1988-12-29 | 1992-10-28 | Mitsui Petrochemical Ind | Process for producing pyrimidine derivatives and pharmaceutical compositions |
| WO1999023091A1 (fr) * | 1997-11-03 | 1999-05-14 | Boehringer Ingelheim Pharmaceuticals, Inc. | Composes heterocycliques aromatiques convenant comme anti-inflammatoires |
| MXPA01009077A (es) * | 1999-03-12 | 2002-03-27 | Boehringer Ingelheim Pharma | Composiciones heterociclicos aromaticos como agentes anti-inflamatorios. |
| JP2004531571A (ja) * | 2001-05-25 | 2004-10-14 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | サイトカイン生産のインヒビターとしてのカルバメート及びオキサミド化合物 |
| EP1408950B1 (fr) * | 2001-07-11 | 2007-04-25 | Boehringer Ingelheim Pharmaceuticals Inc. | Methodes permettant de traiter des maladies induites par les cytokines |
-
2005
- 2005-04-20 EP EP05740166A patent/EP1747204B1/fr active Active
- 2005-04-20 TW TW094112578A patent/TW200538105A/zh unknown
- 2005-04-20 KR KR1020067024157A patent/KR100883937B1/ko not_active IP Right Cessation
- 2005-04-20 MX MXPA06012189A patent/MXPA06012189A/es active IP Right Grant
- 2005-04-20 PT PT05740166T patent/PT1747204E/pt unknown
- 2005-04-20 DE DE602005008581T patent/DE602005008581D1/de not_active Expired - Fee Related
- 2005-04-20 CA CA002564589A patent/CA2564589A1/fr not_active Abandoned
- 2005-04-20 SI SI200530424T patent/SI1747204T1/sl unknown
- 2005-04-20 SM SM200600037T patent/SMAP200600037A/it unknown
- 2005-04-20 BR BRPI0510128-0A patent/BRPI0510128A/pt not_active IP Right Cessation
- 2005-04-20 PL PL05740166T patent/PL1747204T3/pl unknown
- 2005-04-20 CA CA002564587A patent/CA2564587A1/fr not_active Abandoned
- 2005-04-20 CN CNA2005800124183A patent/CN1946700A/zh active Pending
- 2005-04-20 WO PCT/US2005/013869 patent/WO2005105758A1/fr active Application Filing
- 2005-04-20 AU AU2005238484A patent/AU2005238484A1/en not_active Abandoned
- 2005-04-20 WO PCT/US2005/013868 patent/WO2005105757A1/fr active Application Filing
- 2005-04-20 DK DK05740166T patent/DK1747204T3/da active
- 2005-04-20 JP JP2007509683A patent/JP2007534689A/ja active Pending
- 2005-04-20 RU RU2006140694/04A patent/RU2338739C2/ru active
- 2005-04-20 ES ES05740166T patent/ES2311223T3/es active Active
- 2005-04-20 CN CNA2005800125453A patent/CN1946701A/zh active Pending
- 2005-04-20 AT AT05740166T patent/ATE402927T1/de not_active IP Right Cessation
- 2005-04-20 MX MXPA06012188A patent/MXPA06012188A/es not_active Application Discontinuation
- 2005-04-20 EP EP05740317A patent/EP1737830A1/fr not_active Withdrawn
- 2005-04-20 TW TW094112581A patent/TW200539883A/zh unknown
- 2005-04-20 JP JP2007509682A patent/JP2007534688A/ja active Pending
- 2005-04-21 US US11/111,612 patent/US7402589B2/en not_active Expired - Fee Related
- 2005-04-21 US US11/111,581 patent/US7449474B2/en not_active Expired - Fee Related
- 2005-04-22 PE PE2005000451A patent/PE20060258A1/es not_active Application Discontinuation
- 2005-04-22 PE PE2005000450A patent/PE20060338A1/es not_active Application Discontinuation
- 2005-04-22 AR ARP050101610A patent/AR050411A1/es not_active Application Discontinuation
- 2005-04-22 AR ARP050101611A patent/AR048874A1/es not_active Application Discontinuation
-
2006
- 2006-10-05 IL IL178459A patent/IL178459A0/en unknown
- 2006-11-08 NO NO20065142A patent/NO20065142L/no not_active Application Discontinuation
- 2006-11-09 ZA ZA200609326A patent/ZA200609326B/xx unknown
- 2006-11-21 MA MA29478A patent/MA28638B1/fr unknown
-
2008
- 2008-09-30 HR HR20080489T patent/HRP20080489T3/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL177278A0 (en) | Pyrazolotriazines as kinase inhibitors | |
| HRP20130810T1 (en) | Sulphonylpyrroles as hdac inhibitors | |
| TWI369354B (en) | Cytokine inhibitors | |
| EP1756092A4 (fr) | Inhibiteurs novateurs de protéines rho-kinases | |
| IL179398A0 (en) | Dpp-ib inhibitors | |
| ZA200610593B (en) | Diphenylimidazopyrimidine and -imidazole amines as inhibitors of ß-secretase | |
| HK1091210A1 (en) | Cytokine inhibitors | |
| IL179280A0 (en) | Substituted 2-quinolyl-oxazoles useful as pde4 inhibitors | |
| ZA200608221B (en) | Thiadlazolidinones as GSK-3 Inhibitors | |
| ZA200707650B (en) | Azolylacylguanidines as ß-secretase inhibitors | |
| ZA200700181B (en) | Aryl-pyridine derivatives as 11-beta-HSD1 inhibitors | |
| IL181720A0 (en) | Bicyclic amides as kinase inhibitors | |
| ZA200702394B (en) | Indozolone derivatives as 11b-HSD1 inhibitors | |
| IL177253A0 (en) | PYRROLE-DERIVATIVES AS FACTOR Xa INHIBITORS | |
| PT1763517E (pt) | Derivados de pirimidina como inibidores 11beta-hsd1 | |
| IL177470A0 (en) | BETA-AMINOACID-DERIVATIVES AS FACTOR Xa INHIBITORS | |
| ZA200701527B (en) | Composition comprising statin | |
| ZA200707086B (en) | Cytokine inhibitors | |
| EP1816194A4 (fr) | Inhibiteurs de prolifération spécifique aux cellules cancéreuses | |
| ZA200700650B (en) | Bicyclic amides as kinase inhibitors | |
| GB0421355D0 (en) | Inhibitors | |
| ZA200609326B (en) | Tri-substituted ureas as cytokine inhibitors | |
| GB0421356D0 (en) | Inhibitors | |
| EP1712566A4 (fr) | Inhibiteur de cytokine inflammatoire | |
| GB0408300D0 (en) | Novel inhibitors |